Objective The effectiveness and safety of misoprostol have been reported for abortion up to
22 weeks' gestation. The objective of this study was to demonstrate the effectiveness and …

Objective To evaluate outcomes with mifepristone 200 mg orally followed 24–48 h later by
misoprostol 800 mcg vaginally for medical abortion at 64–70 days of gestation. Study design …

OBJECTIVE: To provide evidence regarding the safety, efficacy, and acceptability of 200 mg
mifepristone followed by home administration of 400 μg oral misoprostol METHODS: The …

Objective The present study was conducted with the aim to assess and comparatively
evaluate the safety and efficacy of misoprostol alone and mifepristone with misoprostol for …

BACKGROUND: A 400 mcg dose of sublingual misoprostol has high efficacy and few side
effects when used with 200 mg mifepristone for medical abortion through 63 days' gestation …

BACKGROUND: The aim of the study was to assess efficacy and safety of administering 200
mg of mifepristone between 36 and 48 h before the insertion of 800 mcg of vaginal …

OBJECTIVE: The study was conducted to compare the efficacy of two different dose
regimens of misoprostol administered vaginally in combination with mifepristone for second …

Increased access to medical methods of abortion could significantly reduce maternal
mortality, especially in developing countries. In light of the political and commercial …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

INTRODUCTION: A growing body of literature has shown that misoprostol alone could be
effective for early medical abortion. We evaluated seven potential regimens in women up to …